Approved Study Database

Ref. No. Scientific Title Principal investigator
2014.403 Impact of macrolide non susceptibility in Mycoplasma pneumoniae on childhood respiratory diseases Prof Ip Margaret
2014.404 A Randomized Phase 2 Study of LY2157299 versus LY2157299 – Sorafenib Combination versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma Prof. CHAN Stephen Lam
2014.405 Clinical bioequivalence study on two gliclazide 80 mg tablet formulations Prof. LEE Vincent Hon Leung
2014.406 Effects of thromboelastography-guided transfusion algorithm versus standard clinical practice on post-operative bleeding and blood product use after cardiac surgery: a randomized, controlled trial Dr. LUK Ting Hin
2014.407 Comparing the effect of a Polyurethane endotracheal tube (PU-ETT) and Polyurethane subglottic secretion drainage endotracheal tube (PU-SSD-ETT) on ventilator associated pneumonia (VAP): a randomized control trial Mr CHAN Wing Keung David
2014.408 Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA) Prof. CHAN Anthony
2014.409 An Open Label, Randomized Phase 3 Clinical Trial of Nivolumab vs Therapy of Investigator's Choice in Recurrent or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (SCCHN) Prof. CHAN Anthony Tak Cheung
2014.410 End-of-life decisions in Neonatal Intensive Care Unit: A Retrospective Analysis of Modes of Deaths in the NICU Dr Chan Chi Ngong, Lawrence
2014.411 Neoadjuvant chemotherapy for HER2-positive breast cancers in Hong Kong Dr Suen Joy See Joyce
2014.412 Neural responses to pitch in Cantonese-speaking children with autism spectrum disorders Prof. WONG Patrick Chun Man
2014.413 Systemic aerobic exercise training in young children with Autism Spectrum Disorder Dr. CHAN Dorothy
2014.414 Respiratory pathogens in the PICU Prof. HON Ellis Kam Lun
2014.415 Prospective Sample Collection - Evaluation of novel markers for early detection of Hepatocellular Carcinoma (HCC) - Prof. CHAN Henry Lik Yuen
2014.416 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Subjects with Chronic HCV Prof. CHAN Henry Lik Yuen
2014.417 A phase III, 52 week, randomized, double-blind, 3-arm parallel group study, comparing the efficacy, safety and tolerability of the fixed dose triple combination FF/UMEC/VI with the fixed dose dual combinations of FF/VI and UMEC/VI, all administered once-daily in the morning via a dry powder inhaler in subjects with chronic obstructive pulmonary disease Prof. HUI David Shu Cheong
2014.419 Risk of Intracerebral Haemorrhage in Patients Taking Oral Anticoagulants for Atrial Fibrillation with Cerebral Microbleeds. A Prospective Study in Warfarin - Phase II Study. (IPAAC-Warfarin Phase II Study) Dr. SOO Yannie Oi Yan
2014.420 Physiotherapy ambulation training protocol for people with Parkinson's disease Dr. CHAN Anne Yin Yan
2014.421 Liver stiffness measurement by two transient elastography machines – comparison between Fibroscan® and Fibrotouch® Dr Wong Lai Hung, Grace
2014.422 Lifestyle modification in patients with common urological cancers: A follow-up epidemiological study. Prof. NG Chi Fai
2014.423 Retrospective cohort study on Speckle Strain echocardiography in predicting clinical outcomes in Cardiac patients Dr. CHI Wai Kin
2014.424 DECLARE Dapagliflozin Effect on CardiovascuLAR Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients with Type 2 Diabetes Prof. MA Ronald Ching Wan
2014.425 A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy - SONAR: Study Of Diabetic Nephropathy with Atrasentan Dr. OZAKI Risa
2014.426 A STUDY TO EVALUATE THE EFFECT OF BTI320 (SUGARDOWN®) ON POST-PRANDIAL HYPERGLYCAEMIA IN HIGH RISK CHINESE SUBJECTS WITH PRE-DIABETES Dr. LUK Andrea On Yan
2014.427 Does repetitive, assistive sit-to-stand training facilitate the independence in sit-to-stand? A randomized controlled trial Mr Ng Chee Man
2014.428 Mechanisms of circadian rhythms in the progression of REM sleep behavior disorder towards neurodegeneration Prof. ZHANG Jihui
2014.429 Circadian gene expression alteration of insomnia disorder in an ex vivo cellular model: a pilot study Prof. ZHANG Jihui
2014.430 A prospective cohort study on the effectiveness of psychological preparation conducted by Hospital Play Specialist in reducing need of sedation and level of anxiety in paediatric patients who undergo MRI Ms LOY Tammy Sze wah
2014.431 A study of the hemodynamics of narrowed head and neck vessels Prof. YU Simon
2014.432 A study of the hemodynamics of aortic dissection before and after endovascular repair Prof. YU Simon
2014.433 Comparing mindfulness meditation and Buddhist meditation on well-being among university students: A randomized controlled trial Mr. Tang Chung Sing
2014.434 Sulfur Amino Acids as Risk Factors for Obesity and Related Morbidities in Older Chinese People Prof. KWOK Timothy
2014.435 Molecular epidemiology and evolutionary genetics study of Neisseria gonorrhoeae with decreased susceptibility to cephalosporins between Hong Kong and Guangdong asso. Prof. Harwell Joseph
2014.436 Validation of Brief Assessment of Prospective Memory (Hong Kong Chinese version) for older adults with cognitive impairment and early dementia Ms Law Siu Tuen, Daphne
2014.437 Effectiveness of peer-led Wellness Recovery Action Planning (WRAP) on Persons in recovery and youth people in Hong Kong Prof. MAK Winnie Wing Sze
2014.438 Apps to Quit: Ecological Momentary Assessment-Intervention for Psychotropic Substance Abusers. A Pilot Study Prof Tang Wai Kwong
2014.440 A double-blind, randomised, placebo controlled Phase III study of nintedanib plus best supportive care (BSC) versus placebo plus BSC in patients with colorectal cancer refractory to standard therapies. Prof. MA Brigette
2014.441 A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) Dr. LUK Andrea
2014.442 MicroRNAs for Liver Disease Progression Determination of Non-invasive, Blood-Based Biomarkers for the Prognosis of Chronic Liver Disease Prof. WONG Wai Sun
2014.443 A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) Dr. TSANG Chiu Chi
2014.444 Cost-Effectiveness Analysis of XELOX versus FOLFOX-4 regimens with or without Bevacizumab in the first line management of metastatic colorectal cancer (MCRC) in Hong Kong Prof. Lee Vivian Wing Yan
2014.445 Establish a national registry to search for the risk factors, etiology, and neurodegenerative progression of REM sleep behavior disorder Prof. ZHANG Jihui
2014.446 “Community Acquired Central Nervous System Infections” (CACNSI) survey Dr Wong Chun Kwan Bonnie
2014.448 Determination of labor progression patterns using non-invasive, ultrasound based, multiple parameters in Chinese population Dr. CHOR Chung Ming
2014.449 Placental iodine and thyroxine transport - relationship with pregnancy complications and perinatal outcome. Mr. Ng Yu Tai Russell
2014.450 A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Pyridorin® (pyridoxamine dihydrochloride) in Subjects with Nephropathy Due to Type 2 Diabetes (PIONEER) Dr. OZAKI Risa
2014.451 A Phase IV Post-market, Observational, Retrospective & Prospective, Multi-centre Study of Lacosamide (Vimpat®) in Refractory, Partial-Onset Epilepsy patients in Hong Kong Dr. LEUNG Howan
2014.452 MSBase: An international Registry dedicated to evaluating outcomes data in Multiple Sclerosis (MS) Dr. LAU Alexander Yuk-lun
2014.453 Acute Substernal Defibrillation (ASD) Study Dr. CHAN Joseph Yat Sun
2014.455 Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV Professor Chan Paul KS
2014.457 A prospective, multicenter, randomized, double blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masitinib in combination with FOLFIRI (irinotecan, 5-fluorouracil and folinic acid) to placebo in combination with FOLFIRI in second line treatment of patients with metastatic colorectal cancer Prof. LOONG Herbert

Page 122 of 254.